Stay updated on Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4 on the page, indicating a minor update to the study record.
    Difference
    0.1%
    Check dated 2026-05-17T10:09:39.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page’s displayed revision/version identifier was updated from v3.5.2 to v3.5.3, indicating a site or interface software update rather than a change to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-25T18:25:55.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:26:38.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0 and no longer shows Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T20:00:55.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T18:08:12.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    The page update shows a revision from v3.4.1 to v3.4.2. No substantive changes to study content or key details such as eligibility criteria or outcomes are evident.
    Difference
    0.1%
    Check dated 2026-02-13T01:13:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.